1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Fetal and neonatal alloimmune thrombocytopenia in 2022 : a response
(
- Contribution to journal › Letter
- 2022
-
Mark
Antenatal intravenous immunoglobulins in pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia : comparison of neonatal outcome in treated and nontreated pregnancies
(
- Contribution to journal › Article
- 2020
-
Mark
Foetal and neonatal alloimmune thrombocytopenia – The role of the HLA-DRB3*01:01 allele for HPA-1a-immunisation and foetal/neonatal outcome
(
- Contribution to journal › Scientific review
- 2019
-
Mark
HLA-DRB3*01:01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a–immunized women
(
- Contribution to journal › Article
- 2018
-
Mark
Determination of fetal RHD type in plasma of RhD negative pregnant women
(
- Contribution to journal › Article
-
Mark
Screening for fetal and neonatal alloimmune thrombocytopenia - lessons learned from a Norwegian screening program
(
- Contribution to journal › Letter
- 2017
-
Mark
Antenatal management in fetal and neonatal alloimmune thrombocytopenia : A systematic review
(
- Contribution to journal › Scientific review
-
Mark
Prevention of alloimmunization during pregnancy by prednisone and immunoglobulin G-What is the evidence?
(
- Contribution to journal › Debate/Note/Editorial
- 2013
-
Mark
Mechanisms and prevention of alloimmunization in pregnancy.
(
- Contribution to journal › Article